Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
11/2014
11/25/2014US8895606 Proline sulfonamide derivatives as orexin receptor antagonists
11/25/2014US8895587 Insecticidal compounds based on arylthioacetamide derivatives
11/25/2014US8895558 Arylpiperazine-containing pyrrole 3-carboxamide derivatives for treating depressive disorders
11/25/2014US8895554 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes, and Parkinson's disease
11/25/2014US8895535 Pyrrolidinones as MetAP-2 inhibitors
11/20/2014US20140343289 Process for producing solid amino acid
11/20/2014US20140343083 Pyrrolidine derivatives, pharmaceutical compositions and uses thereof
11/20/2014US20140343070 Proton pump inhibitors
11/20/2014US20140342966 Process for preparing alkyl pyroglutamic acids
11/20/2014US20140341986 Biguanide Compositions and Methods of Treating Metabolic Disorders
11/18/2014US8889906 Tetralin and indane derivatives and uses thereof
11/18/2014US8889889 Crosslinked polymers with the crosslinker as therapeutic for sustained release
11/18/2014US8889871 Hepatitis C virus inhibitors
11/18/2014US8889789 Low dielectric constant resin formulation, prepolymer, composition, and composite thereof
11/18/2014US8889727 Topical antifungal agent
11/18/2014US8889716 Transglutaminase TG2 inhibitors, pharmaceutical compositions, and methods of use thereof
11/18/2014US8889674 Piperidine and pyrrolidine derivatives having NPY Y5 receptor antagonism
11/18/2014US8889100 Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
11/13/2014US20140336395 Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid
11/13/2014US20140336376 Pharmaceutical composition for treating diabetes
11/13/2014US20140336235 Substituted biaryl alkyl amides
11/13/2014US20140336227 3-amino lactams as anti-inflammatory agents
11/13/2014US20140336194 Method of treating contrast-induced nephropathy
11/13/2014US20140336187 Methods for treating leishmaniasis
11/13/2014US20140336174 Glucosylceramide Synthase Inhibition For The Treatment Of Collapsing Glomerulopathy And Other Glomerular Disease
11/13/2014US20140336158 Nk1 antagonists
11/13/2014US20140335179 Micronized crystals of atorvastatin hemicalcium
11/11/2014US8883050 Curable colored compositions, color filters and processes for preparing them, liquid crystal display devices, solid-state image sensors, and dye compounds
11/11/2014US8882075 Furnace mount
11/06/2014US20140329854 Novel heterocyclic compounds useful in sirtuin binding and modulation
11/06/2014US20140329833 Lysine demethylase inhibitors for inflammatory diseases or conditions
11/06/2014US20140329815 Inhibitors of c-fms kinase
11/04/2014US8877975 Cycloalkylamines as monoamine reuptake inhibitors
11/04/2014US8877943 Radiotracer precursor and method for preparing the same
11/04/2014US8877815 Substituted carbamoylcycloalkyl acetic acid derivatives as NEP
11/04/2014US8877799 Inorganic salt complexes of vildagliptin
11/04/2014US8877794 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
11/04/2014US8877709 Reversible pegylated drugs
11/04/2014US8877694 Asphaltene dispersant containing lubricating compositions
10/2014
10/30/2014US20140323519 Heterocyclic compounds as b-raf inhibitors for treatment of cancer
10/30/2014US20140323501 Amino-propylene-glycol derivatives, preparation method and pharmaceutical composition and use thereof
10/30/2014US20140323412 Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease
10/28/2014US8872422 Dinaphthyl ethylene derivativce, process for preparing it, film prepared from it, and OLED including the film
10/28/2014US8871976 Chalcone structure fluorescence dye for embryonic stem cell probe
10/28/2014US8871949 Method for preparing FMOC-based hydrolysable linkers
10/28/2014US8871948 (Aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor
10/28/2014US8871784 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
10/23/2014US20140316088 Metathesis catalysts and methods thereof
10/23/2014US20140315972 RS)-2-(2-oxo-4-phenylpyrrolidin-1-yl)acetamide compound having modulatory activity with a commensurate effect, pharmaceutical substance (variants) and its application, composition (variants) thereof
10/23/2014US20140315905 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
10/23/2014US20140315898 N-arylamidine-substituted trifluoroethyl sulfide derivatives as acaricides and insecticides
10/23/2014US20140314685 Ion channel modulating compounds and uses thereof
10/21/2014US8865918 Androgen receptor modulator compounds and methods
10/21/2014US8865917 Hardeners for thermosettable resin compositions
10/21/2014US8865916 Functionalized diamond nanoparticles
10/21/2014US8865914 Fluorescent probes for detection of copper
10/21/2014US8865909 Anti-biofilm agents
10/21/2014US8865903 Continuous process for the alkylation of cyclic tertiary amines
10/21/2014US8865720 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/21/2014US8865714 Piperazine compound capable of inhibiting prostaglandin D synthase
10/16/2014US20140309275 Sphingosine Analogs, Compositions, and Methods Related Thereto
10/16/2014US20140309274 Lipidic Furan, Pyrrole, and Thiophene Compounds for Treatment of Cancer, Neurological Disorders, and Fibrotic Disorders
10/16/2014US20140309273 Compounds and methods of treating obesity
10/16/2014US20140309193 Novel pyrrole derivatives
10/16/2014US20140309190 Bicyclic aryl sphingosine 1-phosphate analogs
10/16/2014US20140309174 Hemiasterlin derivatives and uses thereof in the treatment of cancer
10/14/2014US8859785 Volatile group 2 metal precursors
10/14/2014US8859782 Process for the preparation of 1-H-pyrrolidine-2,4-dione derivatives
10/14/2014US8859779 Catalyst complex with carbene ligand
10/14/2014US8859610 Crystalline glycopyrrolate tosylate
10/14/2014US8859602 Inhibitors of c-fms kinase
10/14/2014US8859599 Androgen receptor modulating compounds, preparation and uses thereof
10/14/2014US8859591 Glucagon receptor modulators
10/14/2014US8859590 Inhibitors of BACE1 and methods for treating Alzheimer's disease
10/14/2014US8859555 Lysine Specific Demethylase-1 inhibitors and their use
10/14/2014US8859544 Indolizine derivatives, process for the preparation thereof and therapeutic use thereof
10/09/2014WO2014165127A1 Pyrrole amide inhibitors
10/09/2014WO2014165075A1 Antibacterial agents
10/09/2014WO2014161888A1 N-phenyl-carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
10/09/2014US20140303384 Novel phenicol antibacterials
10/09/2014US20140303383 Method for purifying levo-oxiracetam
10/09/2014US20140303378 Process for producing pyrrole compound
10/09/2014US20140303222 Dual-acting imidazole antihypertensive agents
10/09/2014US20140301976 Novel hydroxamates as therapeutic agents
10/09/2014US20140301948 [f-18]-labeled l-glutamic acid, [f-18]-labeled l-glutamine, derivatives thereof and use thereof and processes for their preparation
10/09/2014DE19882327B3 Verfahren zur Herstellung von Maleinsäureanhydridpolymeren, die Struktureinheiten von Maleinsäuremonoamid und/oder dessen cyclischem Imid umfassen Methods for the preparation of maleic anhydride polymers which contain structural units of maleic acid monoamide and / or its cyclic imide
10/08/2014EP2786982A1 Amino-propylene-glycol derivatives, preparation method and pharmaceutical composition and use thereof
10/07/2014US8853423 Indane estrogen receptor modulators and uses thereof
10/07/2014US8853422 Pyrrolidine-2,5-dione derivatives for use in friction modification
10/07/2014US8853421 Crystalline forms of zofenopril calcium
10/07/2014US8853412 Pyrrolidinone derivatives as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
10/07/2014US8853408 Cyclopropylamines as LSD1 inhibitors
10/07/2014US8853392 Benzamide mGluR5 positive allosteric modulators and methods of making and using same
10/07/2014US8853390 Processes for preparing 1,2-substituted cyclopropyl derivatives
10/07/2014US8853281 Cysteine protease inhibitors
10/07/2014US8853255 3-phenoxymethylpyrrolidine compounds
10/07/2014US8853243 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
10/07/2014US8853215 Derivatives of N-acyl-N′-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes
10/02/2014WO2014160940A2 Lipidic furan, pyrrole, and thiophene compounds for treatment of cancer, neurological disorders, and fibrotic disorders
10/02/2014WO2014160649A1 Hydroxamic acid derivatives as lpxc inhibitors for the treatment of bacterial infections
1 2 3 4 5 6 7 8 9 10 11 12 13 14 ... 404